These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11018850)

  • 1. Vanishing bile duct syndrome in Hodgkin's disease: case report.
    Rossini MS; Lorand-Metze I; Oliveira GB; Souza CA
    Sao Paulo Med J; 2000 Sep; 118(5):154-7. PubMed ID: 11018850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanishing bile duct syndrome: a rare cause of jaundice in Hodgkin's lymphoma.
    Amer S; Muqeetadnan M; Rahman A; Nusrat S; Hassan S
    Turk J Gastroenterol; 2013; 24(5):444-6. PubMed ID: 24557970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case.
    Guliter S; Erdem O; Isik M; Yamac K; Uluoglu O
    Tumori; 2004; 90(5):517-20. PubMed ID: 15656342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
    Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
    BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.
    Wong KM; Chang CS; Wu CC; Yin HL
    Kaohsiung J Med Sci; 2013 Nov; 29(11):636-41. PubMed ID: 24183359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
    Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
    Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
    Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
    Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
    Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury.
    Liangpunsakul S; Kwo P; Koukoulis GK
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):323-7. PubMed ID: 11953700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of the common bile duct in Hodgkin's disease : report of three cases (author's transl)].
    Pariente D; Cornud F; Grenier P; Degos F; Nahum H
    Sem Hop; 1981 Dec 18-25; 57(47-48):2027-30. PubMed ID: 6276986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease].
    Allory Y; Métreau J; Zafrani E
    Ann Pathol; 2000 Jan; 20(1):52-5. PubMed ID: 10648987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma].
    Córdoba Iturriagagoitia A; Iñarrairaegui Bastarrica M; Pérez de Equiza E; Zozaya Urmeneta JM; Martínez-Peñuela JM; Beloqui Pérez R
    Gastroenterol Hepatol; 2005 May; 28(5):275-8. PubMed ID: 15871809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin lymphoma associated vanishing bile duct syndrome treated successfully with a brentuximab based regimen.
    Morgan JD; Weishar RC; Kwok RM; Lieuw KM
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37989332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hodgkin’s lymphoma-related vanishing bile duct syndrome].
    Boldizsár S; Rottek J; Schneider T; Varga F; Szaleczky E
    Orv Hetil; 2021 May; 162(22):884-888. PubMed ID: 34052798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.
    Fong M; Boyle S; Gutta N
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30796069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.